Medicine and Dentistry
Surgery
100%
Neoplasm
84%
Recurrent Disease
66%
Diseases
59%
Surgeon
57%
Rectum Cancer
54%
Systematic Review
54%
Prostate Cancer
46%
Quality of Life
41%
Malignant Neoplasm
39%
Infection
37%
Colorectal Surgery
34%
Magnetic Resonance Imaging
34%
Postoperative Complication
33%
Surgical Anastomosis
33%
Colorectal Carcinoma
30%
Laparoscopic Surgery
30%
Colectomy
28%
Surgical Technique
27%
Injury
27%
COVID-19
26%
Cancer Surgery
26%
Randomized Controlled Trial
25%
Thermal Burn
25%
Crohn's Disease
24%
Observational Study
24%
Prognostic Factor
22%
Diagnosis
21%
Radiation Therapy
21%
Meta-Analysis
21%
Surgical Infection
21%
Prevalence
20%
Biopsy Technique
20%
Bariatric Surgery
20%
Odds Ratio
19%
Non Muscle Invasive Bladder Cancer
19%
Overall Survival
19%
Metastatic Carcinoma
19%
Cohort Analysis
19%
Bladder Cancer
18%
Inflammatory Bowel Disease
18%
Retrospective Study
17%
Operation Duration
17%
Multivariate Analysis
17%
Health Care Cost
16%
Anastomosis Leakage
16%
Total Mesorectal Excision
16%
Fistula
16%
Feces Incontinence
16%
Colon Carcinoma
16%
Knee
15%
Colon
15%
Incisional Hernia
15%
Prospective Cohort Study
15%
Bladder
15%
Chemoradiotherapy
15%
Lymph Node
15%
Prospective Study
15%
Oropharyngeal Dysphagia
15%
Pelvis
14%
Surgical Emergency
14%
Head and Neck Squamous Cell Carcinoma
14%
Biological Marker
14%
Liver Transplantation
14%
Bleeding
13%
Stoma
13%
Comorbidity
13%
Chemotherapy
13%
Body Mass Index
13%
Randomized Clinical Trial
13%
Transurethral Resection
13%
Hernioplasty
13%
Transanal Endoscopic Microsurgery
13%
Ulcerative Colitis
13%
Laparotomy
12%
Transitional Cell Carcinoma
12%
Severe Acute Respiratory Syndrome Coronavirus 2
12%
Carcinoma
12%
Suture
12%
Splenectomy
12%
Hernia
12%
Incision
12%
Allograft
12%
Conservative Treatment
12%
Cystectomy
12%
Total Knee Arthroplasty
11%
Sleeve Gastrectomy
11%
Open Surgery
11%
Neck
11%
Computer Assisted Tomography
11%
Disease Free Survival
11%
Adverse Event
11%
Retroperitoneal Lymph Node Dissection
11%
Lower Anterior Resection
10%
Diverticulitis
10%
Urinary System
10%
Ileo-Anal Pouch
10%
Outpatient
10%
Hazard Ratio
10%
Abdominal Cancer
10%
Keyphrases
Tumor
52%
Colorectal Cancer
50%
Surgeons
43%
Colorectal Surgery
37%
Quality of Life
33%
Spain
31%
Surgical Treatment
30%
Crohn's Disease
28%
Risk Factors
27%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
26%
Postoperative Complications
24%
Prostate Cancer
24%
Functional Outcome
24%
After Surgery
23%
COVID-19
23%
Confidence Interval
22%
Magnetic Resonance Imaging
22%
Prognostic Factors
20%
Inflammatory Bowel Disease
20%
Meta-analysis
20%
Bariatric Surgery
20%
Resection
19%
Multivariate Analysis
19%
Odds Ratio
18%
Randomized Controlled Trial
18%
Clinical Outcomes
18%
Fecal Incontinence
18%
Laparoscopic Approach
17%
High Risk
17%
Non-muscle Invasive Bladder Cancer (NMIBC)
17%
Liver Transplantation
16%
Oropharyngeal Dysphagia
16%
Systematic Meta-analysis
16%
Laparoscopic Surgery
16%
Laparoscopy
16%
Surgical Site Infection
16%
Surgical Technique
16%
Radiotherapy
15%
Overall Survival
15%
Consecutive Patients
14%
Transanal Total Mesorectal Excision (taTME)
14%
Bladder Cancer
14%
Barcelona
14%
Transanal Endoscopic Microsurgery
13%
Incisional Hernia
13%
Open Surgery
13%
Postoperative Mortality
12%
Oncological Outcomes
12%
Anastomosis
12%
Prospective Cohort Study
12%
Comorbidity
12%
Emergency Surgery
12%
Local Recurrence
12%
Disease-free Survival
12%
Weight Loss
11%
Ulcerative Colitis
11%
Knee
11%
Upper Tract Urothelial Carcinoma
11%
Anastomotic Leak
11%
Hospital Stay
11%
Computed Tomography
11%
Body Mass Index
11%
Morbid Obesity
11%
Colon
10%
COVID-19 Pandemic
10%
Total Knee Arthroplasty
10%
Surgical Management
10%
Sleeve Gastrectomy
10%
Recurrence Rate
10%
Multicenter Cohort Study
10%
Surgical Procedures
10%
Ileal Pouch-anal Anastomosis
10%
Operative
10%
Locally Advanced Rectal Cancer
10%
Operative Time
10%
Clinical Practice
10%
No Significant Difference
10%
Older Patients
10%
Colon Cancer
10%
Obesity
10%
Rectal Tumor
10%
Prospective Randomized Trial
10%
Androgen Deprivation Therapy
10%
Patients with Prostate Cancer
9%
Predictive Factors
9%
Oncologic
9%
Postoperative Outcomes
9%
Europe
9%
Transanal Endoscopic Surgery
9%
Visual Acuity
9%
Laparoscopic Splenectomy
9%
Patient Management
9%
Postoperative Morbidity
9%
Hazard Ratio
9%
Patient Selection
9%
Chemotherapy
9%
Abdominal
9%
Hernia
9%
Radical Prostatectomy
9%
Transurethral Resection
9%